MikeFranzJanicekMD

PubMed

• 64 citations
  Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing
  Thomas P. Slavin, Kimberly C. Banks, Darya Chudova, Geoffrey R. Oxnard, Justin I. Odegaard, Rebecca J. Nagy, Kar Wing Kevin Tsang, Susan L. Neuhausen, Stacy W. Gray, M...> ;Journal of Clinical Oncology. 2018 Oct 19
• 18 citations
  TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair defi...
  Phillip Gray, Pei Tsai, Daniel Chen, Sitao Wu, Jayne Hoo, Wenbo Mu, Bing Li, Huy Gia Vuong, Hsiao Mei Lu, Navanjot Batth, Sara Willett, Lisa Uyeda, Swati Shah, Chia Li...> ;Oncotarget. 2018 Apr 17
• 7 citations
  TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
  Phillip Gray, Huy Gia Vuong, Pei Tsai, Hsaio Mei Lu, Wenbo Mu, Vickie Hsuan, Jayne Hoo, Swati Shah, Lisa Uyeda, Susanne Fox, Harshil Patel, Mike Janicek, Sandra Brown,...> ;Oncotarget. 2016 Sep 8
• 19 citations
  Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer.
  Alan N. Gordon, Michael Teneriello, Mike F. Janicek, Jeffrey F. Hines, Peter Lim, M. Dwight Chen, Luis Vaccarello, Howard D. Homesley, Scott McMeekin, Tiana L. Burkhol...> ;Gynecologic Oncology. 2011 Dec 1
• 23 citations
  Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer.
  Lisa M. Hess, Setsuko K. Chambers, Kenneth D. Hatch, Alton V. Hallum, Mike F. Janicek, Joseph Buscema, Matthew Borst, Cynthia Johnson, Lisa D. Slayton, Yuda Chongpison...> ;The Journal of Supportive Oncology. 2010 Nov 1
• 45 citations
  Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Res...
  Setsuko K. Chambers, Mary C Clouser, Amanda F. Baker, Denise J. Roe, Haiyan Cui, Molly Brewer, Kenneth D. Hatch, Michael Gordon, Mike F. Janicek, Jeffrey D. Isaacs, Al...> ;Clinical Cancer Research. 2010 Nov 1
• Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Final safety ...
  Teneriello MG, Gordon AN, Lim P, Janicek M> ;J. Clin. Oncol.. 2010-06-20
• Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Interim analy...
  Gordon AN, Teneriello MG, Spirtos N, Janicek MF, Goss T, Wang Y, Orlando M, Obasaju CK, Gill JF, Tai DF> ;J. Clin. Oncol.. 2008-05-20
• Phase I study of OSI-211 (liposomal lurtotecan) in combination with liposomal doxorubicin (LD) every 3 weeks in patients (pts) with advanced solid tumors; final analys...
  Mendelson DS, Brewer M, Janicek M, Breitenbach E, Barrett E, Hamilton M, Ptazynski M, van Duym C, Gordon M> ;J. Clin. Oncol.. 2005-06-01
• 94 citations
  Cervical cancer: prevention, diagnosis, and therapeutics.
  Mike F. Janicek, Hervy E. Averette> ;CA. 2001 Mar 1
• 14 citations
  Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer.
  Wolfgang M.J. Schoell, Ramin Mirhashemi, Bai Liu, Mike F. Janicek, Eckhard R. Podack, Manuel Penalver, Hervy E. Averette> ;Gynecologic Oncology. 1999 Sep 1
• 89 citations
  Epidemiology and biology of cervical cancer.
  Wolfgang M.J. Schoell, Mike F. Janicek, Ramin Mirhashemi> ;Seminars in Surgical Oncology. 1999 Apr 1
• 4 citations
  Critical care issues in cervical cancer management
  Ramin Mirhashemi, Mike F. Janicek, Wolfgang M.J. Schoell> ;Seminars in Surgical Oncology. 1999 Apr 1
• 62 citations
  Close vaginal margins as a prognostic factor after radical hysterectomy.
  Ricardo Estape, Roberto Angioli, Marilu Madrigal, Mike F. Janicek, Carmen Gomez, M. Penalver, Hervy E. Averette> ;Gynecologic Oncology. 1998 Mar 1
• 9 citations
  Significance of Intraperitoneal Cytology in Patients Undergoing Radical Hysterectomy
  Ricardo Estape, Roberto Angioli, Felicia A. Wagman, Marilu Madrigal, Mike F. Janicek, Parvin Ganjei-Azar, M. Penalver, Hervy E. Averette> ;Gynecologic Oncology. 1998 Feb 1
• 69 citations
  Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis.
  Wolfgang Schoell, Doris Pieber, Olaf Reich, Manfred Lahousen, Mike F. Janicek, Fatih Guecer, Raimund Winter> ;Cancer. 1997 Dec 15
• 2 citations
  p53 Interference and Growth Inhibition in p53-Mutant and Overexpressing Endometrial Cancer Cell Lines
  Mike F. Janicek, Roberto Angioli, Ayçe D. Unal, Bernd-Uwe Sevin, Marilu Madrigal, Ricardo Estape, Hervy E. Averette> ;Gynecologic Oncology. 1997 Jul 1
• Advanced mucinous adenocarcinoma in pregnancy.
  Roberto Angioli, Salih Yasin, Ricardo Estape, Mike F. Janicek, Abdallah M. Adra, Christine Sopo, Maryam Minhaj, Manuel Penalver> ;Oncology Reports. 1997 May 1
• 29 citations
  In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma
  Marilu Madrigal, Mike F. Janicek, Bernd-Uwe Sevin, James P. Perras, Ricardo Estape, Manuel Penalver, Hervy E. Averette> ;Gynecologic Oncology. 1997 Jan 1
• 16 citations
  Combination Anti-Gene Therapy Targeting c-myc and p53 in Ovarian Cancer Cell Lines
  Mike F. Janicek, Bernd-Uwe Sevin, Hoa N. Nguyen, Hervy E. Averette> ;Gynecologic Oncology. 1995 Oct 1
• 1 citations
  The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society.
  C J Mettlin, G P Murphy, L S McGinnis, H R Menck> ;Cancer. 1995 Sep 15
• 50 citations
  The National Cancer Data Base report on ovarian cancer. American College of Surgeons Commission on Cancer and the American Cancer Society.
  H E Averette, M F Janicek, H R Menck> ;Cancer. 1995 Sep 15
• 29 citations
  Ovarian carcinoma : a review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention
  Hoa N. Nguyen, Hervy E. Averette, Mike F. Janicek> ;Cancer. 1994 Jul 15
• 69 citations
  Invasive Endometrial Cancer in Uteri Resected for Atypical Endometrial Hyperplasia
  Mike F. Janicek, Neil B. Rosenshein> ;Gynecologic Oncology. 1994 Mar 1
• Use of lonidamine to potentiate the effect of cisplatin and carboplatin on platinum resistant human ovarian cancer cells.
  Angioli, R., Janicek, M., Sevin, B., Estape, R., Averette, H., Koechli, O., Untch, M., Penalver, M.> ;Int J Oncol. 1997 Oct
• Join now to see all

Journal Articles

• Cervical cancer: prevention, diagnosis, and therapeutics.  
  Janicek MF, Averette HE, CA Cancer J Clin. 2001 Mar-Apr;51(2):92-114; quiz 115-8
• Management of Colouterine Fistulas.  
  Estape RE, Angioli R, Janicek MF, Madrigal ML, Medina C, Penalver M, Journal of Pelvic Surgery 2000: 6(3), 170-173
• Critical care issues in cervical cancer management.  
  Mirhashemi R, Janicek MF, Schoell WM, Semin Surg Oncol. 1999 Apr-May;16(3):267-74

Books/Book Chapters

• Expert Consultations in Gynecologic Oncology. 
  Chapter: Apparent Stage I Endodermal Sinus Tumor in a Woman Desiring to Preserve Fertility 
  Mike F Janicek, and Bernd-Uwe SevinEditors: Markman and Belinson.Marcel Dekker, Inc, New York
• Principles and Practice of Gynecologic Oncology. 
  Page 297 - 326Hervy E. Averette, Mike F. Janicek, Tom E. NolanEditors: Hoskins, Perez, and Young. Lippincott Williams & WilkinsEdition 3,
• Principles and Practice of Gynecologic Oncology. 
  Chapter: Perioperative and Critical Care (Chapter 12) 
  Hervy E. Averette and Mike F. JanicekEditors: Hoskins, Perez, and Young.Lippincott Williams & WilkinEdition 2,

Abstracts/Posters

• The National Cancer Data Base report on ovarian cancer.
  Averette HE, Janicek MF, Menck HR., Cancer 76(6):1096-103, American College of Surgeons Commission on Cancer and the American Cancer Society
• Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Safety and ...
  A. Gordon, M. Teneriello, P. Lim, M. Janicek, T. Burkholder, Y. Wang, M. Orlando, C. Obasaju, J. Gill, D. Tai, ASCO
• Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Interim anal...
  A. N. Gordon, M. G. Teneriello, N. Spirtos, M. F. Janicek, T. Goss, Y. Wang, M. Orlando, C. K. Obasaju, J. F. Gill and D. F. Tai, Journal of Clinical Oncology, 2008 ASCO Annual Meeting, Vol 26, No 15S (Supplement), 5536

Lectures

• Diagnosis and Management of Endometrial Hyperplasias 
  Ob/Gyn Grand Rounds/CME, Scottsdale Osborn, Phoenix, AZ
• Hormone Hype and Hysteria. 
  Update on Gynecologic Oncolgy Cedars Sinai Med Center
• Los Angeles Oncology Nursing Society. 
  Phoenix Oncology Nursing Soc, Phoenix, AZ
• Hereditary Aspects of Breast-Ovarian Cancers. 
  St. Joe's Hosp
• Overview of Gyn Oncology. 
  hoenix and Scottsdale, AZ
• Controversies in Hormones and Cancer. 
  Alza Sponsored Dinner Lecture, Phoenix, AZ, 1997
• Molecular Genetics of Hereditary Breast/Ovarian Ca. 
  Scottsdale Shea Tumor Board, Scottsdale, AZ
• Hereditary Breast/Ovarian Ca. 
  Red Hot Mammas; PV Hospital, Phoenix, Arizona
• Hyp and Hysteria: Hormone Replacement Therapy and Cancer. 
  Coral Gables, Florida
• Immunotherapy of Cervical Cancer. 
  Joint Cancer Conference of Florida, Orlando, Florida, 1996
• Molecular Genetics in Gynecologic Oncology Controversies in Hormone Replacement Therapy. 
  Miami and Orlando, Florida
• Management of Viral Genital Tract Infections: HPV andHSV. 
  22nd Annual Ob/Gyn Course Eden Roc Resort, Miami Beach, Florida
• Diagnosis and Management of Gynecologic and Breast Cancer: An Update. 
  Alexander Hotel Miami Beach, Florida
• Breast and Ovarian Carcinoma: Susceptibility Genes and Genetic Screening. 
  Alexander Hotel Miami Beach, Florida
• Management of Gynecologic Malignancies: Controversies in Hormone Replacement Therapy. 
  National Cancer Institute of Mexico Mexico City, Mexico
• Clinical Aspects of Endometrial Cancer. 
  Florida Society of Gynecologic Oncologists, Longboat Key, Florida
• Molecular Genetics of Hereditary Cancers Uterine Carcinomas and Sarcoma. 
  21st Annual Comprehensive Ob/Gyn Course, Miami, Florida
• Management of Preinvasive Cervical Lesions. 
  Sylvester Comprehensive Cancer Center Grand Rounds, Miami, FL
• Tamoxifen: Problems & Promises Molecular Biology of HPV. 
  Dept. Ob/Gyn Grand Rounds, U. Miami, FL
• Anti-gene Therapy Targeting p53 and c-myc. 
  Dallas, TX
• BRCA1 Update for the Gynecologist. 
  Sylvester Cancer Center Health and Wellness Conference Hotel Intercontinental, Miami, FL
• Combination Anti-Gene Therapy Targeting c-myc and p53in Endometrial Cancer Cell Lines. 
  Platform Presentation& Press Conference, ASCO Annual Meeting Dept. Ob/Gyn Grand Rounds, U. Miami,
• Cytoprotectants in Gyn Oncology. 
  Maricopa County/St. Joe's Hosp, Phoenix, AZ
• Ovarian Cancer: Update. 
  Memorial Regional Hospital Hollywood, Florida
• Join now to see all